Evidence map›Paper›PMID 21839740›Full record

ArticleJournal of immunological methods2011

Transcriptional profiling of TLR-4/7/8-stimulated guinea pig splenocytes and whole blood by bDNA assay.

Lance K Ching, Farah Mompoint, Jeffrey A Guderian, Alex Picone, Ian M Orme, Rhea N Coler, Steven G Reed, Susan L Baldwin

Abstract read
In one paragraph

Article in Journal of immunological methods, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization.Journal of controlled release : official journal of the Controlled Release Society · 2014
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lance K ChingInfectious Disease Research Institute, 1124 Columbia Street, Suite 400, Seattle, WA 98104, USA.
Farah Mompoint
Jeffrey A Guderian
Alex Picone
Ian M Orme
Rhea N Coler
Steven G Reed
Susan L Baldwin
Infectious Disease Research Institute · USUniversity of Washington · USColorado State University · US

Funding

Response Therapies for MDR-TBU01AI070456 · NIAID · COLORADO STATE UNIVERSITY · PI ORME, IAN M · 2006 to 2010
$6.4M
Development and Manufacture of Adjuvants for Vaccines Targeting MDR TuberculosisU01AI078054 · NIAID · ACCESS TO ADVANCED HEALTH INSTITUTE · PI COLER, RHEA N · 2008 to 2011
$6.2M
NIAID NIH HHS HHSN272200800045CNIAID NIH HHS U01 AI070456NIAID NIH HHS U01 AI078054PHS HHS 1U01 A1078054
6 · The paper itself

Abstract

Toll-like receptor (TLR) agonists are currently being examined as adjuvants for vaccines, with several lead candidates now in licensed products or in late-stage clinical development. Guinea pigs are widely used for preclinical testing of drugs and vaccines; however, evaluation of TLR agonists in this model is hindered by the limited availability of immunological tools and reagents. In this study, we validated the use of a branched-chain DNA (bDNA) assay known as the QuantiGene Plex 2.0 Reagent System for measuring innate cytokine and chemokine mRNA levels following TLR stimulation of guinea pig cells. Gene expression for T-helper-1 (Th1) polarizing cytokines (TNF-α, IL-1β, IL-12) and chemokines (CXCL1, CCL2) was upregulated following ex vivo stimulation of guinea pig splenocytes and whole blood with TLR-4 or TLR-7/8 agonists. These data confirm the utility of the QuantiGene system both as an alternative to RT-PCR for measuring transcript levels and as a high-throughput screening tool for dissecting the immunological response to TLR stimulation in guinea pigs. Overall, the QuantiGene platform is reliable, reproducible, and sensitive. These agonists have the potential to be used as adjuvant components in vaccines against various pathogens.

Indexed as

TranscriptomeAdjuvants, ImmunologicAminoquinolinesAnimalsBranched DNA Signal Amplification AssayChemokine CCL2Chemokine CXCL1ChemokinesCytokinesFemaleGene Expression ProfilingGuinea PigsImidazolesImiquimodInterleukin-12Interleukin-1betaAdjuvants, ImmunologicAminoquinolinesChemokine CCL2Chemokine CXCL1ChemokinesCytokinesgardiquimodImidazolesImiquimodInterleukin-12Interleukin-1betaLipopolysaccharidesresiquimodToll-Like Receptor 4Toll-Like Receptor 7Toll-Like Receptor 8Toll-Like ReceptorsTumor Necrosis Factor-alpha

Identifiers

PMID21839740
PMCPMC3196045
OpenAlexW2056602408

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.